09128101 is referenced by 3 patents and cites 643 patents.

Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. These include nucleic acids, protein, and circulating structures such as vesicles. Biomarkers can be used for theranostic purposes to select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and can also be used to determine treatment efficacy. The biomarkers can be circulating biomarkers, including vesicles and microRNA.

Title
Biomarkers for theranostics
Application Number
13/581795
Publication Number
9128101 (B2)
Application Date
March 1, 2011
Publication Date
September 8, 2015
Inventor
Daniel Holterman
Phoenix
AZ, US
Andrea Tasinato
Gimel
CH
Traci Pawlowski
Laguna Niguel
CA, US
David Spetzler
Scottsdale
AZ, US
Michael Klass
Oro Valley
AZ, US
George Poste
Cave Creek
AZ, US
Christine Kuslich
Paradise Valley
AZ, US
David D Halbert
Colleyville
TX, US
Agent
Ramin Akhavan
Assignee
Caris Life Sciences Switzerland Holdings
CH
IPC
G01N 33/574
C12Q 1/68
G01N 33/68
G01N 33/53
View Original Source